AI-generated summary
The authors studied human neuroblastoma cells loaded with amyloid-beta and treated them with 670 nm laser light and/or epigallocatechin gallate. They report that both approaches were associated with lower amyloid-beta aggregate amounts than untreated cells, and that laser irradiation increased cell numbers and ATP levels in amyloid-free cells. These are in vitro results, so their relevance to Alzheimer's disease in patients is not established.
- Who or what was studied
- Human neuroblastoma (SH-EP) cells loaded with amyloid-beta(42)
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study was performed in vitro in cultured cells, and the abstract does not report any animal or human testing of the treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Adenosine triphosphate, Near-infrared, Stroke. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.